194 related articles for article (PubMed ID: 26712226)
1. Lymphedema Precautions: Time to Abandon Old Practices?
Ahn S; Port ER
J Clin Oncol; 2016 Mar; 34(7):655-8. PubMed ID: 26712226
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
3. Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs.
Poppe MM; Agarwal JP
J Clin Oncol; 2017 Aug; 35(22):2467-2470. PubMed ID: 28481705
[TBL] [Abstract][Full Text] [Related]
4. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
Doyle B; Al-Mudhaffer M; Kennedy MM; O'Doherty A; Flanagan F; McDermott EW; Kerin MJ; Hill AD; Quinn CM
J Clin Pathol; 2009 Jun; 62(6):534-8. PubMed ID: 19190009
[TBL] [Abstract][Full Text] [Related]
6. Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?
Papakonstantinou A; Foukakis T; Rodriguez-Wallberg KA; Bergh J
J Clin Oncol; 2016 May; 34(14):1573-9. PubMed ID: 26951320
[TBL] [Abstract][Full Text] [Related]
7. The role of axillary dissection in mammographically detected carcinoma.
Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
[TBL] [Abstract][Full Text] [Related]
8. Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor-Positive Breast Cancer.
Wander SA; Mayer EL; Burstein HJ
J Clin Oncol; 2017 Sep; 35(25):2866-2870. PubMed ID: 28580881
[TBL] [Abstract][Full Text] [Related]
9. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
10. [A case of bilateral multiple primary breast cancer].
Waga E; Sakurai K; Fujisaki S; Maeda T; Nagashima S; Hara Y; Tomita R; Suzuki S; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2036-8. PubMed ID: 23267968
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic core biopsy of calcifications highly suggestive of malignancy.
Liberman L; LaTrenta LR; Van Zee KJ; Morris EA; Abramson AF; Dershaw DD
Radiology; 1997 Jun; 203(3):673-7. PubMed ID: 9169687
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association].
Fourneret P; Artignan X; De Cornulier J; Pasquier D; Panh MH; Payan R; Kolodié H; Vincent F; Fric D; Bernard P; Colona M; Bolla M
Cancer Radiother; 2006 Dec; 10(8):550-8. PubMed ID: 16890006
[TBL] [Abstract][Full Text] [Related]
13. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
Vora SA; Wazer DE; Homer MJ
Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
[TBL] [Abstract][Full Text] [Related]
14. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
15. [The difficulty of choosing a treatment strategy for ductal carcinoma in situ of the breast detected by breast cancer screening-a case report].
Suzuki S; Sakurai K; Nagashima S; Fujisaki S; Tomita R; Hara Y; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2408-10. PubMed ID: 24394128
[TBL] [Abstract][Full Text] [Related]
16. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.
White J; Levine A; Gustafson G; Wimbish K; Ingold J; Pettinga J; Matter R; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):791-7. PubMed ID: 7860390
[TBL] [Abstract][Full Text] [Related]
17. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB
Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099
[TBL] [Abstract][Full Text] [Related]
20. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
